Faculty Advisor(s)
Michelle Adams
Abstract
This project details specifics regarding hepatocellular carcinoma and transarterial chemoembolization. Transarterial embolization involves treatment of liver cancer via arterial access. This procedure is the first line of treatment for individuals diagnosed with stage B hepatocellular carcinoma. Indications, contraindications, procedural aspects, and current research are also discussed. Hepatocellular carcinoma is the fifth leading cause of cancer around the world. The TACE procedure can be done using drug eluting beads to embolize or with the use of chemotherapy drugs. The procedure is credited with extending the life span for individuals with this diagnosis. Research shows the procedure has a positive success rate including a complete response to the procedure in 35% of patients and a reduction of tumor in 25% of patients. Side effects of the procedure are minimal, with most side effects being moderate and treatable. Hepatocellular carcinoma was the third leading cause of death in 2020, which emphasizes the need for understanding and implementation of this procedure.
Publication Date
2024
Document Type
Poster
Department
Medical Imaging
Keywords
transarterial chemoembolization, drug-eluting beads, hepatocellular carcinoma, TACE procedure, chemotherapy
Disciplines
Medicine and Health Sciences
Recommended Citation
Pelchar, Alexis, "Transarterial Chemoembolization in Interventional Radiology" (2024). Medical Imaging Senior Posters. 55.
https://digitalcommons.misericordia.edu/medimg_seniorposters/55